CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Interestingly, a strong decrease in Cyp2e1 expression was only detected in cirrhotic NAFLD patients (Figure 8C), which corresponds to the observation in the WD-fed mice, where Cyp2e1 loss was a late event.